TP53 and breast cancer: In an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation,-α-mangostin induced cell-cycle arrest at G1-phase and apoptotic cell death in several breast cancer cell lines, reducing tumor growth and lymph node metastasis [18].